2023-01-01·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
[Botulinum toxin type A (Relatox) in the treatment of chronic migraine in adults: results of phase IIIb, randomized, one-blind, multicenter, active-controlled, parallel-group trial].
Article
作者: Latysheva, N V ; Artemenko, A R ; Naprienko, M V ; Filatova, E G ; Krasavina, D A ; Orlova, O R ; Yakovleva, P N ; Konovalova, Z N ; Shevchenko, V S ; Abramov, V G ; Kurenkov, A L ; Korenko, A N
2023-01-01·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Botulinum toxin type A (Relatox) in transition from medication overuse to non-overuse status in patients with chronic migraine: a subgroup analysis of phase IIIb randomized single-blind multicenter active-controlled parallel-group trial
Article
作者: Naprienko, M V ; Shevchenko, V S ; Konovalova, Z N ; Orlova, O R ; Kurenkov, A L ; Latysheva, N V ; Artemenko, A R ; Krasavina, D A ; Bozhenkina, T V ; Filatova, E G ; Iakovleva, P N ; Abramov, V G ; Korenko, A N
2022-01-01·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Safety and efficacy of the Relatox in the treatment of patients with cervical dystonia (results of a multicenter simple blind comparative randomized study)
Article
作者: Pogoreltseva, O A ; Orlova, O R ; Novikov, S A ; Khatkova, S E ; Pokhabov, D V ; Nikolaev, E A ; Diagileva, V P ; Shevchenko, V S